Most of the ingredients of heparin sodium contain non reducing -L-idopyranosuronic alpha acid 2-O-sulfo- structure, reducing the end of 6-O- -2, 5-, -D- and.
Prevention and treatment of thrombosis and embolism. In the treatment of disseminated intravascular coagulation, the early application of fibrin and coagulation factors can be prevented. Other anticoagulants in vivo, such as cardiac catheterization, cardi
International:0546-7077213
Domestic:0546-7077213
Fax:0546-8208302
Email:market@td-pharm.com
